Company News 15 Apr 2024 Orthocell receives $3.05m R&D tax incentive refund Orthocell has announced that it has received a Research and Development (R&D) Tax Incentive refund of A$3,051,483 for the financial… Orthocell
Company News 25 Mar 2024 Orthocell Successfully Completes Surgeries for Remplir™ US Market Authorisation Orthocell has announced that it has successfully completed the first stage of the Remplir™ US 510(k) market authorisation nerve repair… Orthocell
Company News 22 Feb 2024 Orthocell Completes $3.5M Strategic Placement Orthocell has today announced that it has completed a Company-led Strategic Placement to raise $3.5 million. Orthocell
Company News 13 Feb 2024 Orthocell submits Singapore Regulatory Application for Remplir™ Orthocell has today announced that the Company has submitted a regulatory application to the Health Services Authority of Singapore for… Orthocell
Company News 15 Jan 2024 The Hon Kim Beazley AC Joins Orthocell Board Orthocell has appointed Australia’s former US ambassador and Governor of Western Australia, The Hon Kim Beazley AC, as an Independent… Orthocell
Company News 14 Nov 2023 Positive clinical results for OrthoATI™ Orthocell has today released positive results from our clinical study comparing OrthoATI™ to surgery for the treatment of severe chronic… Orthocell
Company News 24 Aug 2023 Striate+™ re-certified under new European medical device regulations Orthocell has announced that Striate+™dental membrane has received regulatory approval under the new European Medical Device Regulations (MDR). Orthocell
Company News 03 Jul 2023 Inaugural Nerve Transfer and Reconstruction Symposium Orthocell was delighted to co-sponsor the inaugural Nerve Transfer and Reconstruction Symposium at the University of Western Australia last week. Orthocell
Company News This week marks the official launch of Orthocell’s new GMP certified bio-manufacturing facility at the Company headquarters in Perth. 29 May 2023 New Bio-manufacturing Facility Launch Event This week marks the official launch of Orthocell’s new GMP certified bio-manufacturing facility at the Company headquarters in Perth. Orthocell
Company News 29 May 2023 Appointment of John Van Der Wielen as Independent Non-Executive Chairman Orthocell has announced the appointment of Mr. John Van Der Wielen as Orthocell’s new independent Non-Executive Chairman, effective June 1,… Orthocell